CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 28, 2023
Share
CardioComm Solutions, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was CAD 0.251833 million compared to CAD 0.144373 million a year ago. Net loss was CAD 0.029963 million compared to CAD 0.066999 million a year ago.
For the nine months, revenue was CAD 0.701457 million compared to CAD 0.758134 million a year ago. Net loss was CAD 0.010589 million compared to net income of CAD 0.055183 million a year ago.
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Companyâs device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
CARDIOCOMM SOLUTIONS, INC. 
